top of page
ATI-1801
ATI-1801
PIPELINE
ATI-1501
ATI-1701
ATI-1801
STRATEGY
Diverse Pipeline
Business Environment
ABOUT US
Leadership
Board of Directors
COLLABORATORS
INVESTORS
Financial Reports
Proxy Information
Corporate Governance
Legal Counsel & Auditors
Analyst Coverage
SEDAR Filings
Contact IR
NEWS
News 2023
Archives 2022
Archives 2021
Archives 2020
Archives 2019
Archives 2018
Archives 2017
Archives 2016
Media Contact
CONTACT
CAREERS
Career Opportunities
More
Use tab to navigate through the menu items.
News Highlights
News 2021
Archives 2020
Archives 2019
Archives 2016-2018
Media Contact
Media Download Center
News Highlights
News 2022
Archives 2021
Archives 2020
Archives 2019
Archives 2016-2018
Media Contact
Media Download Center
Archives 2018
Archives 2017
Archives 2016
December 21, 2016
Appili Therapeutics Raises $2.2M in Equity Capital to Develop Its Anti-Infective Pipeline
Read More
October 3, 2016
Appili Therapeutics Inc. Appoints Kimberly Stephens as Chief Financial Officer
Read More
May 25, 2016
Appili Raises $3.2M in Seed Round To Develop Novel Antibiotics
Read More
April 12, 2016
Appili Receives Orphan Drug Designation from FDA for ATI-1501: Treating C. difficile in Children
Read More
bottom of page